Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT Interleukin-2 receptor alpha chain binding agent PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hodgkin Disease 1 D006689 ClinicalTrials
Lymphoma, Non-Hodgkin 1 D008228 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109366